FIELD: medicine.
SUBSTANCE: application of a fluridon herbicide (1-methyl-5 (α,α,α-trifluoro-m-tolyl)-3-phenylpyridinon-4) of the structural formula 
(I) as an agent for treatment of oncologic diseases with a disposable dosage from 0.1 mg to 5 g on reception to 3 times a day is offered. It is possible to take fluridon in the form of a dry powder or as an aqueous solution in rectal, intravenous or intraperitoneal manner, in the form of ointment, candles, or inhalant. Efficiency of treatment of oncologic diseases is shown: adenocarcinoma, melanoma with metastasises, carcinoma, non-Hodgkin's lymphoma, liver cancer, glioblastoma, and sarcoma.
EFFECT: development of a substance which suppresses proliferation of cancer cells more effectively than doxorubicine, does not cause by-effects in patients at its use.
8 cl, 5 tbl, 13 ex
